32
Participants
Start Date
October 20, 2008
Primary Completion Date
May 2, 2012
Study Completion Date
April 11, 2014
Maraviroc
Maraviroc will be given dose-adjusted to background HIV treatment (150 mg, 300 mg, or 600 mg twice daily)
University Southern California, Los Angeles
Harbor-UCLA, Torrance
University California San Diego, San Diego
Collaborators (1)
University of California, Los Angeles
OTHER
University of Southern California
OTHER
Pfizer
INDUSTRY
California HIV/AIDS Research Program
OTHER
University of California, San Diego
OTHER